Scarica l'app Stockscreener
0.281
5.16%
0.0138
Dopo l'orario di chiusura:
.28
-0.001
-0.36%
Precedente Chiudi:
$0.2672
Aprire:
$0.2627
Volume 24 ore:
4.59M
Relative Volume:
0.67
Capitalizzazione di mercato:
$33.56M
Reddito:
$436.97M
Utile/perdita netta:
$-35.62M
Rapporto P/E:
-0.942
EPS:
-0.2983
Flusso di cassa netto:
$-10.71M
1 W Prestazione:
+30.64%
1M Prestazione:
+8.08%
6M Prestazione:
-32.34%
1 anno Prestazione:
-82.97%
Intervallo 1D:
$0.2574
$0.3049
Intervallo di 1 settimana:
$0.2454
$0.382
Portata 52W:
$0.2151
$2.10
Accuray Inc Stock (ARAY) Company Profile
Nome
Accuray Inc
Settore
Industria
Telefono
608-824-2800
Indirizzo
1240 DEMING WAY, MADISON, CA
Compare ARAY vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
0.281 | 25.69M | 436.97M | -35.62M | -10.71M | -0.2983 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-02-13 | Iniziato | ROTH MKM | Buy |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-12-22 | Iniziato | Loop Capital | Buy |
| 2020-01-21 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-11-01 | Aggiornamento | Citigroup | Sell → Neutral |
| 2017-12-13 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-11-30 | Iniziato | Lake Street | Buy |
| 2016-12-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-12-22 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2015-11-12 | Iniziato | Citigroup | Sell |
| 2015-05-01 | Reiterato | Dougherty & Company | Buy |
| 2015-01-12 | Iniziato | Northland Capital | Outperform |
| 2014-01-31 | Reiterato | Dougherty & Company | Buy |
| 2014-01-29 | Reiterato | Brean Capital | Buy |
| 2013-11-11 | Reiterato | Dougherty & Company | Buy |
| 2013-08-29 | Reiterato | Dougherty & Company | Buy |
| 2011-09-20 | Reiterato | Ticonderoga | Buy |
| 2010-02-08 | Aggiornamento | Jefferies & Co | Hold → Buy |
| 2009-12-09 | Aggiornamento | UBS | Sell → Neutral |
| 2009-03-09 | Downgrade | Soleil | Buy → Hold |
| 2009-01-30 | Aggiornamento | Piper Jaffray | Neutral → Buy |
| 2008-12-22 | Reiterato | Jefferies & Co | Hold |
| 2008-08-20 | Reiterato | Jefferies & Co | Hold |
Mostra tutto
Accuray Inc Borsa (ARAY) Ultime notizie
Japan Approves Accuray’s Cyberknife M6 System for Radiation Therapy Patients - Medical Product Outsourcing
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Accuray shares jump as Samsung NeuroLogica collaboration update sparks rally - Quiver Quantitative
Accuray Incorporated Stock Analysis: Bearish Trends and Key Levels Near Term - The Cryptonomist
Why Is Accuray Stock Gaining Monday? - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Accuray (ARAY) Partners with Samsung HME America to Advance Cybe - GuruFocus
Accuray Incorporated (ARAY) Partners With Samsung NeuroLogica on Volumetric Imaging for CyberKnife - TradingView
Accuray Stock Price Forecast. Should You Buy ARAY? - StockInvest.us
Accuray, RaySearch to Collaborate on Online Adaptive Radiation Therapy - Imaging Technology News
Accuray Incorporated (ARAY) options chain - Yahoo Finance UK
Accuray Incorporated(NasdaqCM: ARAY) dropped from S&P Global BMI Index - marketscreener.com
What Accuray’s (ARAY) $8 Million RaySearch Deal Means for Its Adaptive Therapy Push - Yahoo Finance
Accuray Inc. (NASDAQ: ARAY) Announces Resale of 6.83M Shares Linked to Warrants Priced at $1.50, $1.25, and $0.01 - Kalkine Media
ACCURAY INC SEC Filing (Sep 14, 2026) - stocktitan.net
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities - Investing News Network
Accuray, RaySearch to Collaborate on Adaptive Radiation Therapy - Bitget
Accuray And Raysearch Agree To Collaboration Integrating Raystation Software - TradingView
Accuray and RaySearch agree to collaboration integrating RayStation software with Accuray platforms to accelerate Accuray’s online adaptive capabilities - TradingView
ARAY Q2 2026 Earnings: EPS Swings to Profit With 103.92% Surprise, Yet Shares Fall 4.58%Retail Earnings Report - dars.gov.et
Accuray (NASDAQ: ARAY) clears 6.8M shares for investors to resell - Stock Titan
TCW GROUP INC Adds to Accuray Inc (ARAY) Stake -- Shares Trade 7 - GuruFocus
Accuray Inc (ARAY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Accuray swaps $40M debt for equity, raises $15M cash from TCW - scanx.trade
Accuray Inc (NASDAQ: ARAY) Discloses 18.7% Beneficial Ownership by TCW Including Warrants - Kalkine Media
Accuray | 4: Statement of changes in beneficial ownership of securities-10% Owner TCW GROUP INC - Moomoo
[SCHEDULE 13D/A] ACCURAY INC Amended Major Shareholder Report - Stock Titan
Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter - Yahoo Finance
Accuray Inc FY 2026: Revenue $401.95M, EPS ($0.4) — 10-K Summary - TradingView
Accuray (ARAY) sends definitive proxy to shareholders - Stock Titan
Penny-priced Accuray (NASDAQ: ARAY) warrants set up lender share resales - Stock Titan
Accuray Inc - TradingKey
Accuray Fiscal Q4 Swings to Loss, Revenue Falls - Moomoo
ARAY|Accuray Inc|Price:0.295|Chg%:-0.020 - TradingKey
Accuray Inc (ARAY) (Q4 2026) Earnings Call Highlights: Strategic - GuruFocus
ARAY Looks 77.3% Undervalued on GF Value™ Despite Financial Chal - GuruFocus
Accuray Incorporated Q4 2026 Earnings Call Summary - Yahoo Finance
Accuray earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Accuray Incorporated Q4 Operating Expenses US - Moomoo
Aug 19 (Reuters)Accuray Incorporated Q4 Ne - Moomoo
Accuray (ARAY) Telefonkonferenz zu den Ergebnissen des 4. Quartals des Geschäftsjahres 2026: Servicewachstum, Rückgang der Produktumsätze - TradingKey
Earnings call transcript: Accuray posts mixed Q4 2026 results as revenue slips - Investing.com Canada
Accuray Q4 2026 Earnings Call: Complete Transcript - Benzinga
Accuray Incorporated reports results for the quarter ended June 30Earnings Summary - TradingView
Is Accuray Inc (ARAY) a Value Trap After Q4 Earnings Miss? EPS - GuruFocus
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results - investingnews.com
Accuray Q4 Results: EPS beats estimate, sales miss by 4.16% - scanx.trade
ARAY Looks 78.0% Undervalued on GF Value™ but Faces Profitabilit - GuruFocus
ARAY Looks 78.0% Undervalued on GF Value™ - GuruFocus
Accuray: Fiscal Q4 Earnings Snapshot - marketscreener.com
Accuray posts narrower-than-feared Q4 loss as cost cuts exceed targets - Investing.com Canada
Accuray Inc Azioni (ARAY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Accuray Inc Azioni (ARAY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Peralta Leonel | SVP, Chief Operations Officer |
Feb 28 '26 |
Option Exercise |
0.00 |
83,723 |
0 |
83,723 |
| MAYER STEVEN F | Director |
Feb 20 '26 |
Buy |
0.56 |
54,875 |
30,878 |
1,545,620 |
| MAYER STEVEN F | Director |
Feb 18 '26 |
Buy |
0.53 |
126,125 |
67,199 |
1,421,745 |
| MAYER STEVEN F | Director |
Feb 19 '26 |
Buy |
0.53 |
69,000 |
36,598 |
1,490,745 |
| Scott Byron C | Director |
Dec 31 '25 |
Option Exercise |
0.00 |
9,433 |
0 |
162,727 |
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):